Status:
COMPLETED
Side Effects of Bone Marrow Derived CD133 Transplantation in Cerebral Palsy
Lead Sponsor:
Royan Institute
Conditions:
Cerebral Palsy
Eligibility:
All Genders
4-12 years
Phase:
PHASE1
Brief Summary
Cerebral palsy (CP) is condition, sometimes thought of as a group of disorders that can involve brain and nervous system functions such as movement, learning, hearing, seeing, and thinking.Cerebral pa...
Detailed Description
Our study evaluate the side effects of bone marrow derived CD133 cells transplantation in 4-12years old patients with cerebral palsy.first all the patients undergone a comprehensive evaluation(physica...
Eligibility Criteria
Inclusion
- A diagnosis of spastic quadriplegic CP
- Children must be between the ages of 4 and 12 years
- Children must be cleared by an orthopedic surgeon for risk of hip subluxation or dislocation and cannot have significant scoliosis (curvature \> 40 degrees)
- Children must be seizure-free or seizure controlled
Exclusion
- Children who have a diagnosis of "mixed" types of CP (i.e. athetosis) or other movement disorders (i.e. ataxia)
- Children who have had a selective dorsal rhizotomy, are presently are receiving intrathecal Baclofen, or have changed their spasticity medications in the past 6 months.
- Children who have a metallic or electrical implants
Key Trial Info
Start Date :
October 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
May 1 2012
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT01404663
Start Date
October 1 2011
End Date
May 1 2012
Last Update
March 7 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Royan Institute
Tehran, Iran